))
Clinical Trial Principal Investigator Duties in Clinical Trials
Manage episode 452102742 series 3506216
İçerik Darshan Kulkarni tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Darshan Kulkarni veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
The FDA has stressed the critical importance of adequate supervision and monitoring in clinical trials to ensure they are conducted properly. A key figure responsible for this oversight is the Principal Investigator (PI), as outlined in 21 CFR 32.6. The PI must ensure the trial follows the protocol and all applicable regulations, and that the rights, safety, and welfare of the trial participants are protected, including obtaining informed consent.
Consistently, the FDA has raised concerns about two major areas:
1. Drug Control: Investigators are required to maintain control and proper documentation of the drugs being used in the trial. A recurring issue is the failure to track where the drugs go.
2. FDA Form 1572 Compliance: Investigators must personally certify compliance with all requirements, supervise all aspects of the study, and take responsibility for participant safety. However, problems often arise with the form being incomplete, unsigned, or improperly submitted.
For assistance with clinical trial compliance, reach out to the Kulkarni Law Firm.
137 bölüm
Paylaş
